{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:10:56Z","timestamp":1791306656026,"version":"4.3.1"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001424","name":"ALF","doi-asserted-by":"publisher","award":["ALFGBG-433841"],"award-info":[{"award-number":["ALFGBG-433841"]}],"id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ghir.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:52:20Z","timestamp":1434689540000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Reviewing the safety of GH replacement therapy in adults"],"prefix":"10.1016","volume":"25","author":[{"given":"Kirstine","family":"Stochholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-8440","authenticated-orcid":false,"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2015.06.006_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ghir.2007.05.005","article-title":"Management of growth hormone deficiency in adults","volume":"17","author":"Nilsson","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.1.02191","article-title":"Incidence of GH deficiency \u2014 a nationwide study","volume":"155","author":"Stochholm","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2013.77","article-title":"Diagnosis and treatment of growth hormone deficiency in adults","volume":"9","author":"Kargi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0025","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1359\/jbmr.2002.17.6.1081","article-title":"The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial","volume":"17","author":"Bex","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.1.02317","article-title":"Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency","volume":"156","author":"Gotherstrom","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2008-1538","article-title":"Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults","volume":"94","author":"Gotherstrom","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0045","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"Gotherstrom","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02176","article-title":"Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?","volume":"155","author":"Koltowska-Haggstrom","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0055","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0060","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2015.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2015.06.006_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2015.06.006_bb0075","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jcem.87.4.8394","article-title":"GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis","volume":"87","author":"Johannsson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1993.tb00974.x","article-title":"Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency","volume":"38","author":"Ros\u00e9n","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2265.1996.728550.x","article-title":"Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study","volume":"44","author":"Moller","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2265.1997.1660984.x","article-title":"The safety profile of GH replacement therapy in adults","volume":"46","author":"Chipman","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1210\/jcem.87.5.8454","article-title":"Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms","volume":"87","author":"Kehely","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1210\/jc.2013-3665","article-title":"Effects of testosterone and growth hormone on the structural and mechanical properties of bone by micro-MRI in the distal tibia of men with hypopituitarism","volume":"99","author":"Al Mukaddam","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.2008.03391.x","article-title":"GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence","volume":"70","author":"Arnold","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0115","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jcem.87.7.8593","article-title":"Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients","volume":"87","author":"Attanasio","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0120","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2011-0448","article-title":"Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis","volume":"96","author":"Attanasio","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0125","first-page":"3184","article-title":"Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency","volume":"83","author":"Baum","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2796.1995.tb01137.x","article-title":"Cardiovascular effects of prolonged growth hormone replacement in adults","volume":"237","author":"Beshyah","year":"1995","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ghir.2015.06.006_bb0135","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/jc.2010-2819","article-title":"Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency","volume":"96","author":"Biller","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11102-012-0422-8","article-title":"12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency","volume":"16","author":"Biller","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2015.06.006_bb0145","first-page":"970","article-title":"Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency","volume":"85","author":"Biller","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01971","article-title":"Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial","volume":"153","author":"Bollerslev","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2007.08.015","article-title":"Impact of 5years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults","volume":"57","author":"Cenci","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2015.06.006_bb0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11102-009-0182-2","article-title":"Effects of 5years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency","volume":"12","author":"Cenci","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2015.06.006_bb0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ghir.2006.03.012","article-title":"Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study","volume":"16","author":"Chihara","year":"2006","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ghir.2007.12.001","article-title":"Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD)","volume":"18","author":"Chihara","year":"2008","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0175","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ghir.2008.02.002","article-title":"Efficacy and safety of individualized growth hormone treatment in adult Japanese patients with growth hormone deficiency","volume":"18","author":"Chihara","year":"2008","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-11-0286","article-title":"Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study","volume":"165","author":"Child","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0185","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2265.2007.03135.x","article-title":"Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours","volume":"68","author":"Chung","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3346\/jkms.1994.9.2.169","article-title":"Growth hormone replacement therapy in adults with growth hormone deficiency; thrice weekly low dose administration","volume":"9","author":"Chung","year":"1994","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ghir.2015.06.006_bb0195","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2012-2940","article-title":"Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy","volume":"98","author":"Claessen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0200","first-page":"1371","article-title":"Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers","volume":"81","author":"de Boer","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0205","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.thromres.2010.08.028","article-title":"Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: correlations with PAI-1 and t-PA plasma levels","volume":"126","author":"Di Minno","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ghir.2013.09.001","article-title":"Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation","volume":"23","author":"Elbornsson","year":"2013","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-11-1072","article-title":"Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency","volume":"166","author":"Elbornsson","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/EJE-12-1083","article-title":"Fifteen years of GH replacement improves body composition and cardiovascular risk factors","volume":"168","author":"Elbornsson","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-11-0886","article-title":"Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency","volume":"166","author":"Elbornsson","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0230","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jcem.87.6.8542","article-title":"Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults","volume":"87","author":"Ezzat","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/eje.0.1490499","article-title":"Circulating IGF-I levels in monitoring and predicting efficacy during long-term GH treatment of GH-deficient adults","volume":"149","author":"Ezzat","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2015.06.006_bb0240","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ghir.2004.03.013","article-title":"Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults","volume":"14","author":"Feldt-Rasmussen","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0245","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1210\/jc.2012-2006","article-title":"Discontinuing long-term GH replacement therapy \u2014 a randomized, placebo-controlled crossover trial in adult GH deficiency","volume":"97","author":"Filipsson Nystrom","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0250","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1210\/jcem.86.11.8018","article-title":"Hypothalamo\u2013pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy","volume":"86","author":"Frajese","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0255","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0260","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/EJE-10-0317","article-title":"Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy","volume":"163","author":"Giavoli","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0265","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-978591","article-title":"Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement","volume":"32","author":"Gomez","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0275","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2006-1487","article-title":"A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults","volume":"92","author":"Gotherstrom","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.2004.02181.x","article-title":"The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients","volume":"62","author":"Gotherstrom","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0285","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2265.1995.tb00536.x","article-title":"Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study","volume":"43","author":"Hansen","year":"1995","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0290","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2217\/pgs.11.113","article-title":"Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults","volume":"12","author":"Hartleb","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ghir.2015.06.006_bb0295","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/jc.2012-2684","article-title":"Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients","volume":"98","author":"Hartman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0300","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1530\/eje.0.1460807","article-title":"Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?","volume":"146","author":"Hatrick","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0305","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1210\/jc.2003-030346","article-title":"Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Hoffman","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0310","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1210\/jc.2007-0458","article-title":"Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone","volume":"92","author":"Holmer","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0315","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.psyneuen.2012.09.008","article-title":"Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy","volume":"38","author":"Holmer","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ghir.2015.06.006_bb0320","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.070811","article-title":"Fracture incidence in GH-deficient patients on complete hormone replacement including GH","volume":"22","author":"Holmer","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0325","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2265.1995.tb02690.x","article-title":"Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency","volume":"42","author":"Holmes","year":"1995","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0330","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2011.01.001","article-title":"Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency","volume":"21","author":"Jorgensen","year":"2011","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0340","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2005.02282.x","article-title":"Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors","volume":"62","author":"Jostel","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0345","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2265.1998.00439.x","article-title":"Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults","volume":"48","author":"Kann","year":"1998","journal-title":"Clin. Endocrinol."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2015.06.006_bb0350","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1530\/EJE-09-0328","article-title":"From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum \u2014 a KIMS analysis","volume":"161","author":"Klose","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/dc11-0449","article-title":"Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study","volume":"35","author":"Luger","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2015.06.006_bb0360","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0365","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jc.2009-1611","article-title":"Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement","volume":"95","author":"Miller","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0370","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.2000.01104.x","article-title":"Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database","volume":"53","author":"Monson","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0375","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1210\/jc.2004-0832","article-title":"The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy","volume":"90","author":"Mukherjee","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem.87.1.8146","article-title":"GH-deficient survivors of childhood cancer: GH replacement during adult life","volume":"87","author":"Murray","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0385","first-page":"552","article-title":"Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood","volume":"80","author":"Nass","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0390","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0306-4530(03)00151-3","article-title":"The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism","volume":"29","author":"Oertel","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ghir.2015.06.006_bb0395","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-09-0572","article-title":"Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy","volume":"161","author":"Olsson","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0400","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1530\/EJE-12-0077","article-title":"Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10years of follow-up","volume":"166","author":"Olsson","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0405","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijcard.2006.12.069","article-title":"Short- and long-term effects of growth hormone on the heart","volume":"124","author":"Perez-Berbel","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0410","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1054\/ghir.1999.0091","article-title":"The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy","volume":"9","author":"Rosenfalck","year":"1999","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0415","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.1.02346","article-title":"Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study","volume":"156","author":"Sathiavageeswaran","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0420","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/jc.2003-030126","article-title":"Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study","volume":"88","author":"Shalet","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0425","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1507\/endocrj.EJ13-0083","article-title":"Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study","volume":"60","author":"Shimatsu","year":"2013","journal-title":"Endocr. J."},{"key":"10.1016\/j.ghir.2015.06.006_bb0430","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","article-title":"Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study","volume":"56","author":"Smith","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2265.2002.01493.x","article-title":"Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency","volume":"56","author":"Smith","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0440","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1359\/jbmr.070205","article-title":"Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency","volume":"22","author":"Snyder","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2010.10.005","article-title":"The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database","volume":"21","author":"Spielhagen","year":"2011","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0450","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0455","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults","volume":"87","author":"Svensson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0460","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ghir.2003.12.001","article-title":"Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption","volume":"14","author":"Svensson","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0465","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2002-020901","article-title":"Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength","volume":"88","author":"Svensson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0470","first-page":"2373","article-title":"Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency","volume":"84","author":"ter Maaten","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0475","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1359\/jbmr.1998.13.5.891","article-title":"Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and \u22125 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy","volume":"13","author":"Thoren","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2015.06.006_bb0480","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1210\/jc.2014-1013","article-title":"Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis","volume":"99","author":"Tritos","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0485","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-14-0069","article-title":"Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults","volume":"171","author":"van Bunderen","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0490","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults","volume":"96","author":"van Bunderen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0495","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2265.1993.tb02387.x","article-title":"Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males","volume":"39","author":"Vandeweghe","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0500","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2265.1997.3041112.x","article-title":"Two years of replacement therapy in adults with growth hormone deficiency","volume":"47","author":"Verhelst","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0505","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.1997.2801076.x","article-title":"Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3years","volume":"47","author":"Wallymahmed","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0510","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0515","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1992.tb02901.x","article-title":"Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study","volume":"36","author":"Whitehead","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0520","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.1998.00462.x","article-title":"Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency","volume":"48","author":"Wiren","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0525","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2265.2009.03612.x","article-title":"Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects","volume":"72","author":"Woodmansee","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0530","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ghir.2015.06.006_bb0535","first-page":"2069","article-title":"The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis","volume":"80","author":"de Boer","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0540","first-page":"580","article-title":"Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men","volume":"20","author":"de Boer","year":"1996","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2015.06.006_bb0545","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0550","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2015.06.006_bb0555","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2014-1814","article-title":"Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency","volume":"99","author":"Stochholm","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.006_bb0560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2015.06.006_bb0565","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2015.06.006_bb0570","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2015.06.006_bb0575","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cen.12132","article-title":"Predictors of the effects of 4years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency \u2014 a KIMS database analysis","volume":"79","author":"Tritos","year":"2013","journal-title":"Clin. Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:48:45Z","timestamp":1761086925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637415300083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1096637415300083"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2015.06.006","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviewing the safety of GH replacement therapy in adults","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}